Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Anti-money Laundering (AML) - Company Evaluation Report, 2025" has been added to ResearchAndMarkets.com's offering.The Anti-Money Laundering...
-
Multicenter study sponsored by the National Cancer Institute
-
New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla VenturesCHARM’s AI-designed menin inhibitor overcomes resistance mutations with the potential...
-
New investors NEA and SR One lead round alongside existing investors OrbiMed, F-Prime, NVIDIA and Khosla VenturesCHARM’s AI-designed menin inhibitor overcomes resistance mutations with the potential...
-
Dublin, Aug. 29, 2025 (GLOBE NEWSWIRE) -- The "AML and KYC - Anti-Money Laundering & Know Your Customer Training (December 8, 2025)" training has been added to ResearchAndMarkets.com's...
-
Dublin, Aug. 21, 2025 (GLOBE NEWSWIRE) -- The "AML and KYC - Anti-Money Laundering & Know Your Customer Training (ONLINE EVENT: October 10, 2025)" has been added to ResearchAndMarkets.com's...
-
– Live video webcast on Wednesday, August 20th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage...
-
Aptose Reports Second Quarter 2025 Results
-
BUENOS AIRES, Argentina, July 31, 2025 (GLOBE NEWSWIRE) -- Durante los últimos meses, el país fue testigo de cómo enormes volúmenes de datos personales —incluyendo información sensible vinculada a...
-
BUENOS AIRES, Argentina, July 31, 2025 (GLOBE NEWSWIRE) -- In recent months, the country has witnessed how vast amounts of personal data — including sensitive information linked to official...